MetLife Investment Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $640K | Hold |
11,577
| – | – | ﹤0.01% | 1631 |
|
|
2025
Q4 | $433K | Hold |
11,577
| – | – | ﹤0.01% | 1868 |
|
|
2025
Q3 | $468K | Hold |
11,577
| – | – | ﹤0.01% | 1834 |
|
|
2025
Q2 | $296K | Hold |
11,577
| – | – | ﹤0.01% | 1967 |
|
|
2025
Q1 | $247K | Sell |
11,577
-1,419
| -11% | -$31.7K | ﹤0.01% | 2087 |
|
|
2024
Q4 | $273K | Hold |
12,996
| – | – | ﹤0.01% | 2136 |
|
|
2024
Q3 | $293K | Hold |
12,996
| – | – | ﹤0.01% | 2077 |
|
|
2024
Q2 | $218K | Buy |
12,996
+1,140
| +10% | +$18.3K | ﹤0.01% | 2184 |
|
|
2024
Q1 | $153K | Hold |
11,856
| – | – | ﹤0.01% | 2335 |
|
|
2023
Q4 | $137K | Hold |
11,856
| – | – | ﹤0.01% | 2444 |
|
|
2023
Q3 | $151K | Hold |
11,856
| – | – | ﹤0.01% | 2359 |
|
|
2023
Q2 | $162K | Hold |
11,856
| – | – | ﹤0.01% | 2399 |
|
|
2023
Q1 | $182K | Hold |
11,856
| – | – | ﹤0.01% | 2276 |
|
|
2022
Q4 | $159K | Hold |
11,856
| – | – | ﹤0.01% | 2386 |
|
|
2022
Q3 | $158K | Hold |
11,856
| – | – | ﹤0.01% | 2442 |
|
|
2022
Q2 | $227K | Sell |
11,856
-3,247
| -21% | -$61.5K | ﹤0.01% | 2229 |
|
|
2022
Q1 | $301K | Buy |
15,103
+5,110
| +51% | +$103K | ﹤0.01% | 2096 |
|
|
2021
Q4 | $204K | Hold |
9,993
| – | – | ﹤0.01% | 2042 |
|
|
2021
Q3 | $215K | Hold |
9,993
| – | – | ﹤0.01% | 2049 |
|
|
2021
Q2 | $289K | Hold |
9,993
| – | – | ﹤0.01% | 1919 |
|
|
2021
Q1 | $244K | Hold |
9,993
| – | – | ﹤0.01% | 1945 |
|
|
2020
Q4 | $194K | Hold |
9,993
| – | – | ﹤0.01% | 2006 |
|
|
2020
Q3 | $174K | Hold |
9,993
| – | – | ﹤0.01% | 1943 |
|
|
2020
Q2 | $263K | Hold |
9,993
| – | – | ﹤0.01% | 1738 |
|
|
2020
Q1 | $242K | Hold |
9,993
| – | – | ﹤0.01% | 1588 |
|
|
2019
Q4 | $248K | Hold |
9,993
| – | – | ﹤0.01% | 1855 |
|
|
2019
Q3 | $213K | Hold |
9,993
| – | – | ﹤0.01% | 1909 |
|
|
2019
Q2 | $317K | Hold |
9,993
| – | – | ﹤0.01% | 1759 |
|
|
2019
Q1 | $330K | Hold |
9,993
| – | – | ﹤0.01% | 1706 |
|
|
2018
Q4 | $321K | Hold |
9,993
| – | – | ﹤0.01% | 1632 |
|
|
2018
Q3 | $429K | Hold |
9,993
| – | – | ﹤0.01% | 1628 |
|
|
2018
Q2 | $460K | Hold |
9,993
| – | – | 0.01% | 1450 |
|
|
2018
Q1 | $397K | Hold |
9,993
| – | – | ﹤0.01% | 1508 |
|
|
2017
Q4 | $335K | Buy |
+9,993
| New | +$355K | ﹤0.01% | 1641 |
|
Other funds holding PAHC
VCM
VPM
N
MetLife Investment Management's PAHC Position: Q1 2026 in Review
MetLife Investment Management held its Phibro Animal Health (PAHC) position steady in Q1 2026 at 11,577 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.
MetLife Investment Management first reported a position in PAHC in Q4 2017 and has held it in 34 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- MetLife Investment Management held 11,577 shares of Phibro Animal Health worth $640K as of Q1 2026.
- MetLife Investment Management left its Phibro Animal Health share count unchanged in Q1 2026.
- Phibro Animal Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1631 holding.
- MetLife Investment Management first reported a position in Phibro Animal Health in Q4 2017 and has held it in 34 quarters since.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.